Hospira, Inc.

Hospira chief scientific officer returns

New Market Study Published: Hospira, Inc. (HSP) - Financial and Strategic SWOT Analysis Review

FDA warns Hospira—again

Hospira's Former CSO Returns

Amgen, Hospira and Sandoz Named Among Top Pharmaceutical Companies with Greatest Biosimilar Drug Potential in United States

Hospira reappoints Sumant Ramachandra

Lawsuit: Supplier 'hoodwinked' Hospira in contract bid

Markman Hearing A Likely Clearing Event For Cubist - Decision Any Day

Synta Is a Run-Up Trade Into ASCO Lung Cancer Data

Hospira Reappoints Dr. Sumant Ramachandra Chief Scientific Officer